← All organizations

Highest phase reached
Phase 3
First clinical trial
Dec 8, 2017Last known activity
Jul 13, 2018
Acquired by Sorrento Therapeutics, Inc. on Mar 22, 2019
Timeline
2010s
- Jan 1, 2013
Semnur Pharmaceuticals, Inc.— Founded
- Mar 22, 2019
Sorrento Therapeutics, Inc.— Acquired By
Drugs by trial phase (1 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT03613662Study directorPhase 1Jul 13, 2018
- NCT03613662Lead sponsorPhase 1Jul 13, 2018
- NCT03372161Study directorPhase 3Dec 8, 2017
- NCT03372161Lead sponsorPhase 3Dec 8, 2017
Details
- Founded
- Los Altos, CA, US Jan 1, 2013
- Last known activity
- Jul 13, 2018